Drugs / FMP2.1/AS02A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00460525 | May 2007 → Jul 2009 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMP2.1/AS02A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00460525 ↗ |
| Modality | Vaccine | “the Plasmodium falciparum vaccine candidate FMP2.1/AS02A” PMID 17442466 ↗ Mar 2007 |